X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA STRIDES SHASUN LTD NATCO PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x 33.0 14.0 234.7% View Chart
P/BV x 16.8 1.9 883.4% View Chart
Dividend Yield % 0.7 0.5 124.4%  

Financials

 NATCO PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
STRIDES SHASUN LTD
Mar-16
NATCO PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs8771,413 62.1%   
Low Rs424848 49.9%   
Sales per share (Unadj.) Rs223.4353.3 63.2%  
Earnings per share (Unadj.) Rs31.123.4 132.9%  
Cash flow per share (Unadj.) Rs40.341.0 98.3%  
Dividends per share (Unadj.) Rs5.005.00 100.0%  
Dividend yield (eoy) %0.80.4 173.8%  
Book value per share (Unadj.) Rs219.5320.4 68.5%  
Shares outstanding (eoy) m33.0789.35 37.0%   
Bonus/Rights/Conversions PAESOP-  
Price / Sales ratio x2.93.2 91.0%   
Avg P/E ratio x20.948.3 43.3%  
P/CF ratio (eoy) x16.127.6 58.6%  
Price / Book Value ratio x3.03.5 84.0%  
Dividend payout %16.121.4 75.3%   
Avg Mkt Cap Rs m21,504100,988 21.3%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m1,1284,988 22.6%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m7,38931,564 23.4%  
Other income Rs m1671,212 13.8%   
Total revenues Rs m7,55632,776 23.1%   
Gross profit Rs m1,7935,213 34.4%  
Depreciation Rs m3041,573 19.4%   
Interest Rs m3661,803 20.3%   
Profit before tax Rs m1,2903,049 42.3%   
Minority Interest Rs m46127 36.6%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m309689 44.8%   
Profit after tax Rs m1,0272,089 49.2%  
Gross profit margin %24.316.5 147.0%  
Effective tax rate %23.922.6 106.0%   
Net profit margin %13.96.6 210.0%  
BALANCE SHEET DATA
Current assets Rs m3,68135,949 10.2%   
Current liabilities Rs m3,12319,402 16.1%   
Net working cap to sales %7.652.4 14.4%  
Current ratio x1.21.9 63.6%  
Inventory Days Days8971 126.2%  
Debtors Days Days59127 46.3%  
Net fixed assets Rs m7,68534,478 22.3%   
Share capital Rs m331894 37.0%   
"Free" reserves Rs m6,67022,601 29.5%   
Net worth Rs m7,25928,632 25.4%   
Long term debt Rs m95527,455 3.5%   
Total assets Rs m11,95776,591 15.6%  
Interest coverage x4.52.7 168.0%   
Debt to equity ratio x0.11.0 13.7%  
Sales to assets ratio x0.60.4 149.9%   
Return on assets %11.75.1 229.3%  
Return on equity %14.27.3 194.0%  
Return on capital %20.78.2 253.7%  
Exports to sales %39.448.1 81.8%   
Imports to sales %5.714.5 39.4%   
Exports (fob) Rs m2,90815,192 19.1%   
Imports (cif) Rs m4214,565 9.2%   
Fx inflow Rs m3,44516,612 20.7%   
Fx outflow Rs m7035,292 13.3%   
Net fx Rs m2,74311,320 24.2%   
CASH FLOW
From Operations Rs m1,440717 201.0%  
From Investments Rs m-1,089-22,284 4.9%  
From Financial Activity Rs m-35329,488 -1.2%  
Net Cashflow Rs m-18,073 -0.0%  

Share Holding

Indian Promoters % 52.0 27.7 187.9%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 37.8 20.7%  
FIIs % 16.6 8.6 193.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 25.9 100.4%  
Shareholders   25,395 56,241 45.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare NATCO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 22, 2017 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS